Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | PTGX Protagonist Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 5,130 | 0.00 | 33,126 |
2 Jan 25 | PTGX Protagonist Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 38.98 | 6,584 | 256.64 k | 6,584 |
27 Sep 24 | MTEM Molecular Templates | Stock Option Common Stock | Grant | Acquire A | No | No | 1.41 | 1,000 | 1.41 k | 1,000 |
7 Mar 24 | PTGX Protagonist Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 1.89 | 6,490 | 12.27 k | 27,996 |
7 Mar 24 | PTGX Protagonist Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.89 | 6,490 | 12.27 k | 0 |
2 Jan 24 | PTGX Protagonist Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.42 | 25,700 | 601.89 k | 25,700 |
27 Oct 23 | MTEM Molecular Templates | Stock Option Common Stock | Grant | Acquire A | No | No | 6.06 | 1,000 | 6.06 k | 1,000 |